Marketing-authorisation holder · United States
Alcon
32 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
32 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 32
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BETADINE5% · Solution/drops | Povidone-iodine | United States | Marketed | 1986 |
| BETAXON0.5% base · Suspension/drops | Levobetaxolol | United States | Not marketed | 2000 |
| BETOPTIC PILO0.25% base; 1.75% · Suspension/drops | Betaxolol, Pilocarpine | United States | Not marketed | 1997 |
| BSS0.48mg/ml; 0.3mg/ml; 0.75mg/ml; 3.9mg/ml; 6.4mg/ml; 1.7mg/ml · Solution | Calcium chloride, Magnesium chloride, Potassium chloride, Sodium acetate, Sodium chloride, Sodium citrate | United States | Marketed | 1997 |
| BSS PLUS0.154mg/ml; 0.92mg/ml; 0.184mg/ml; 0.2mg/ml; 0.38mg/ml; 2.1mg/ml; 7.14mg/ml; 0.42mg/ml · Solution | Calcium chloride, Dextrose, Glutathione disulfide, Magnesium chloride, Potassium chloride, Bicarbonate, Sodium chloride, Sodium phosphate | United States | Marketed | 1981 |
| CETAMIDE10% · Ointment | Sulfacetamide | United States | Not marketed | 1972 |
| CETAPRED0.25%; 10% · Ointment | Prednisolone, Sulfacetamide | United States | Not marketed | 1993 |
| DENDRID0.1% · Solution/drops | Idoxuridine | United States | Not marketed | 1963 |
| ECONOCHLOR1% · Ointment | Chloramphenicol | United States | Not marketed | 1974 |
| ECONOCHLOR0.5% · Solution/drops | Chloramphenicol | United States | Not marketed | 1973 |
| ISMOTIC100gm/220ml · Solution | Isosorbide | United States | Not marketed | 1974 |
| ISOPTO CETAMIDE15% · Solution/drops | Sulfacetamide | United States | Not marketed | 1971 |
| ISOPTO CETAPRED0.25%; 10% · Suspension | Prednisolone, Sulfacetamide | United States | Not marketed | 1981 |
| MAXIDEX0.05% phosphate · Ointment | Dexamethasone | United States | Not marketed | 1973 |
| MIOSTAT0.01% · Solution | Carbachol | United States | Marketed | 1972 |
| MYDRIACYL0.5% | 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1% | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Tropicamide | United States | Marketed | 1960 |
| NAPHCON-A0.025%; 0.3% · Solution/drops | Naphazoline, Pheniramine | United States | Marketed | 1994 |
| NAPHCON FORTE0.1% · Solution/drops | Naphazoline | United States | Not marketed | 1974 |
| NAVSTEL0.154mg/ml; 0.92mg/ml; 0.2mg/ml; 0.184mg/ml; 0.38mg/ml; 2.1mg/ml; 7.14mg/ml; 0.42mg/ml · Solution | Calcium chloride, Dextrose, Magnesium chloride, Oxiglutatione, Potassium chloride, Bicarbonate, Sodium chloride, Sodium phosphate | United States | Not marketed | 2008 |
| NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE0.1%; 3.5mg base/ml; 10,000 units/ml · Suspension/drops | Dexamethasone, Neomycin, Polymyxin b | United States | Not marketed | 1986 |
| NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE0.1% phosphate; 3.5mg base/ml · Solution/drops | Dexamethasone, Neomycin | United States | Not marketed | 1986 |
| PANTOPAQUE100% · Injectable | Iophendylate | United States | Not marketed | |
| PHENYLEPHRINE HYDROCHLORIDE10% | 2.5% · Solution/drops | Phenylephrine | United States | Marketed | 2013 |
| PILOPINE HS4% · GEL | Pilocarpine | United States | Not marketed | 1984 |
| PREDNISOLONE SODIUM PHOSPHATE0.11% phosphate | 0.9% phosphate · Solution/drops | Prednisolone | United States | Marketed | 1974 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 32 | 31 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.